Max Robotics — Global Service Robot Directory + US Certification

About

V. Pierrard is a distinguished urologic surgeon whose research focuses on the intersection of innovative, minimally invasive therapies and surgical oncology for prostate cancer. Her major contributions center on evaluating the feasibility and outcomes of radical prostatectomy following novel treatments, particularly vascular targeted photodynamic therapy (VTP) with padeliporfin. In a pivotal 2018 study, she demonstrated that radical prostatectomy after VTP is not only feasible but also yields acceptable early and intermediate oncologic and functional results, challenging the notion that prior focal therapy precludes effective salvage surgery. This work, cited 26 times, has helped define the surgical pathway for patients who progress after non-ablative treatments, bridging the gap between emerging focal therapies and established surgical standards. By systematically assessing perioperative complications and continence and potency recovery, Pierrard has provided critical evidence that guides clinical decision-making for localized prostate cancer. Her research underscores a commitment to expanding treatment options while maintaining rigorous surgical outcomes, making her a key voice in the evolution of prostate cancer management.